Innovation in Dry Eye & MGD Management
EvoTears® is a unique, preservative free lipid layer replacement eye drop for the management of evaporative dry eye and Meibomian Gland Dysfunction (MGD). It consists of a single ingredient* that forms a shield on the outer surface of the tear film to protect against evaporation.
*Perfluorohexyloctane
The clinically proven eye drop for MGD and dry eye disease that directly targets evaporation.1,2
Complete Lipid Replacement
Long Lasting
Relief
Preservative and Phosphate Free
6 months use from opening
Book a call to speak to a member of our team
WHAT IS EVAPORATIVE DRY EYE?
Almost 90% of dry eye patients suffer from Evaporative Dry Eye. This form of Dry Eye occurs when there is an absence of the outer oily lipid layer, leading to evaporation of the aqueous layer. This in turn leads to a reduced tear film, exposing your eye to factors such as wind. This in turn leads to excessive watering, redness, grittiness and overall discomfort to the eye.
What Makes EvoTears® & Perfluorohexyloctane (PFO) Unique
PFO is amphiphilic, meaning it has both hydrophilic and lipophilic properties.
This unique chemistry allows PFO to form a shield on the outer surface of the tearfilm by interacting with both aqueous and lipid layers.
This technology significantly increases the residence time of the product and improves how it spreads over the ocular surface for maximum protection.
PFO acts as a potent evaporation inhibitor.
Since introduction a broad range of clinical and pre-clinical data have confirmed safety, tolerability, efficacy and comfort.
Clinical data on > 2000 subjects with Evaporative Dry Eye Disease supports the safety and efficacy of PFO. Studies ranged from 4 weeks – 1 year and assessed dosages of BID to QID.
Click here for a summary of the clinical research results relating to EvoTears® & Perfluorohexyloctane (PFO).
EvoTears® eases unwanted symptoms associated with evaporative dry eye and MGD such as:
Watery Eyes
Burning Eyes
Red Eyes
Foreign body sensation or grittiness
Book a call to speak to a member of our team
How EvoTears® Works
RELIEVES symptoms of Evaporative Dry Eye Disease and MGD
REPLACES the outer lipid layer of the tear film creating a protective outer shield
INCREASES Tear break up time (TBUT) by 3.3 seconds at 6 weeks3
EvoTears® offers improved tear film stability and symptom relief
for those suffering with Evaporative DED and MGD. In essence, it acts to replace the outer lipid layer, slowing the rate of evaporation of the aqueous layer.
In this video, watch how EvoTears® reduces the evaporation of a simulated tear by more than half.
Small Drops, Big benefits
Water, preservative & phosphate free
Low surface tension
Convenient 3ml bottle – easy to carry and use
>280 drops - 4 drops a day for 70 day
6 months use after opening
No pH/Osmolarity therefore no stinging or burning in the eye
Rapid spread across the ocular surface
Minimal visual impairment
Long lasting relief
Minimises spill over
Water, preservative & phosphate free
No pH/Osmolarity therefore no stinging or burning in the eye
Low surface tension
Rapid spread across the ocular surface
Long lasting relief
Minimal visual impairment
Minimises spill over
Convenient 3ml bottle – easy to carry and use
>280 drops - 4 drops a day for 70 day
6 months use after opening
References
- Tauber J, Berdy GJ, Wirta DL, Krösser S, Vittitow JL; GOBI Study Group. NOV03 for dry eye disease associated with meibomian gland dysfunction: results of the randomized phase 3 GOBI study. Ophthalmology. 2023;130(5):516-524.
- Sheppard JD, Kurata F, Epitropoulos AT, Krösser S, Vittitow JL; MOJAVE Study Group. NOV03 for signs and symptoms of dry eye disease associated with meibomian gland dysfunction: the randomized phase 3 MOJAVE study. Am J Ophthalmol. 2023;252:265-274.
- Steven et al.,2015. Journal of Ocular Pharmacology and Therapeutics, 31(8), pp.498-503.
